spinal muscular atrophy-progressive myoclonic epilepsy syndrome

Spinal muscular atrophy-progressive myoclonic epilepsy syndrome is characterized by hereditary myoclonus and progressive distal muscular atrophy. Less than 10 cases have been reported. Treatment with clonazepam results in complete and lasting improvement of the myoclonus.

Also known as: Jankovic-Rivera syndrome, hereditary myoclonus-progressive distal muscular atrophy syndrome, Jankovic Rivera syndrome, SMAPME, hereditary myoclonus and progressive distal muscular atrophy, myoclonus hereditary progressive distal muscular atrophy, spinal muscular atrophy with progressive myoclonic epilepsy.

Category: General

Looking into spinal muscular atrophy-progressive myoclonic epilepsy syndrome? See the lab tests healthcare providers may use to investigate spinal muscular atrophy-progressive myoclonic epilepsy syndrome, and learn what each one measures.
Explore tests for spinal muscular atrophy-progressive myoclonic epilepsy syndrome
Symptoms

Symptoms associated with spinal muscular atrophy-progressive myoclonic epilepsy syndrome

The following symptoms have been associated with spinal muscular atrophy-progressive myoclonic epilepsy syndrome in medical literature. Not everyone experiences the same symptoms.

Tests

Tests used to investigate spinal muscular atrophy-progressive myoclonic epilepsy syndrome

Healthcare providers may order these tests when evaluating spinal muscular atrophy-progressive myoclonic epilepsy syndrome. Test selection is a clinical decision made by a qualified professional.

CBC with Differential

Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...

Sample: Blood

Comprehensive Metabolic Panel (CMP)

Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...

Sample: Blood

Related conditions

Conditions with overlapping symptoms

These conditions share symptoms with spinal muscular atrophy-progressive myoclonic epilepsy syndrome, which is why a clinical evaluation is important.

FAQ

Frequently Asked Questions

What is spinal muscular atrophy-progressive myoclonic epilepsy syndrome?

spinal muscular atrophy-progressive myoclonic epilepsy syndrome is a health condition described in medical literature. Spinal muscular atrophy-progressive myoclonic epilepsy syndrome is characterized by hereditary myoclonus and progressive distal muscular atrophy. Less than 10 cases have been reported. Treatment with clonazepam results in complete and lasting improvement of the myoclonus.

What are the symptoms of spinal muscular atrophy-progressive myoclonic epilepsy syndrome?

spinal muscular atrophy-progressive myoclonic epilepsy syndrome is associated with 8 symptoms in the medical literature we index, including Dysphagia, Facial palsy, Generalized myoclonic seizure, Generalized-onset seizure, Proximal muscle weakness, Respiratory insufficiency due to muscle weakness. Symptoms vary widely between individuals.

How is spinal muscular atrophy-progressive myoclonic epilepsy syndrome diagnosed or investigated?

A healthcare provider may use a combination of medical history, physical examination, and tests. Common tests associated with spinal muscular atrophy-progressive myoclonic epilepsy syndrome include CBC with Differential, Comprehensive Metabolic Panel (CMP). This information is educational, not a diagnosis.

Is SymptomDatabase.com diagnosing me?

No. SymptomDatabase.com does not provide diagnosis. If you are concerned you may have spinal muscular atrophy-progressive myoclonic epilepsy syndrome, please discuss your symptoms with a qualified healthcare provider.

Educational content only: The information on Symptom Database.com is for educational purposes and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Read our full disclaimer.